GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amerisourcebergen Corporation (holding Co) (ABC) [hlAlert]

Rating:
Outperform
ABC
up 87.07 %

Amerisourcebergen Corporation (holding Co) (ABC) upgraded to Outperform by Leerink Swann

Posted on: Tuesday,  Jun 11, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Amerisourcebergen Corporation (holding Co) (NYSE: ABC) on 06/11/2013, when the stock price was $54.07.
Since then, Amerisourcebergen Corporation (holding Co) has gained 87.07% as of 11/18/2015's recent price of $101.15.
If you would have followed this Leerink Swann 's recommendation on ABC, you would have gained 87.07% of your investment in 890 days.

AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. It distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company operates in the pharmaceutical distribution segment. In October 2008, the Company completed the divestiture of its former workers? compensation business, PMSI. On May 29, 2009, the Company acquired Innomar Strategies Inc.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/11/2013 8:25 AM Buy
None
54.07
as of 12/13/2013
1 Week down  -2.61 %
1 Month down  -0.05 %
3 Months up  13.55 %
1 YTD up  26.59 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/16/2012 9:25 AM Hold
None
37.52

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy